<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02361398</url>
  </required_header>
  <id_info>
    <org_study_id>PUMCH-ARDS-EIT</org_study_id>
    <nct_id>NCT02361398</nct_id>
  </id_info>
  <brief_title>Individualized PEEP Setting by EIT in Patients With ARDS</brief_title>
  <official_title>Individualized Positive End Expiratory Pressure(PEEP) Setting by EIT in Patients With Acute Respiratory Distress Syndrome(ARDS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators conducted a pilot study to compare the effect of Positive End Expiratory&#xD;
      Pressure(PEEP) setting guide by lung electrical impedance tomography(EIT) and ARDS-net&#xD;
      PEEP-FiO2 table on survival in subjects with mild/severe Acute Respiratory Distress&#xD;
      Syndrome(ARDS).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 10, 2018</start_date>
  <completion_date type="Actual">September 30, 2020</completion_date>
  <primary_completion_date type="Actual">September 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>survival</measure>
    <time_frame>28-day</time_frame>
    <description>Non-survive and survive</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Arterial oxygenation</measure>
    <time_frame>72h</time_frame>
    <description>PaO2(mmHg) measured by blood gas analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>length of ICU stay and mechanical ventilated day</measure>
    <time_frame>28days</time_frame>
    <description>Days of ICU stay and received mechanical ventilation(day)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pneumothorax requiring chest tube during first 7 days; barotrauma during first 7 days;</measure>
    <time_frame>7days</time_frame>
    <description>new-onset of pneumothorax and barotrauma</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>the PEEP Setting of ARDS</condition>
  <arm_group>
    <arm_group_label>EIT group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the Individualized PEEP titration by EIT was administered to the patients in the EIT group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>If patients are assigned to the control group, the Individualized PEEP Setting was by PEEP-FiO2 table based on ARDS-net protocol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>the EIT guide the individualized PEEP Setting</intervention_name>
    <description>the EIT guide the individualized PEEP Setting in the EIT group</description>
    <arm_group_label>EIT group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion:&#xD;
&#xD;
          1. acute respiratory distress syndrome with ratio of partial pressure of arterial oxygen&#xD;
             over fraction of inspired oxygen (PaO2:FiO2)&lt;300 and PEEP &gt;5cmH2O&#xD;
&#xD;
          2. Body mass index &lt; =40&#xD;
&#xD;
          3. Written inform consent&#xD;
&#xD;
        Exclusion:&#xD;
&#xD;
          1. pregnantï¼Œintracranial hypertension&#xD;
&#xD;
          2. left ventricular dysfunction (EF&lt;25% )&#xD;
&#xD;
          3. Patients with end-stage conditions(death expected within 90 days)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yun Long, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences,</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>January 13, 2015</study_first_submitted>
  <study_first_submitted_qc>February 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2015</study_first_posted>
  <last_update_submitted>April 7, 2021</last_update_submitted>
  <last_update_submitted_qc>April 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

